Accelerate Diagnostics Inc
NASDAQ:AXDX
| Market Cap (Intraday) | 92.06M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $5.60 |
| 50-Day MA | $6.56 |
| 200-Day MA | $6.71 |
Accelerate Diagnostics Inc Stock, NASDAQ:AXDX
3950 South Country Club Road, Suite 470, Tucson, Arizona 85714
United States of America
Phone: +1.520.365.3100
Number of Employees: 179
Description
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The firm's products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.